Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 594-44-5 Chemical Structure| 594-44-5

Structure of 594-44-5

Chemical Structure| 594-44-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 594-44-5 ]

CAS No. :594-44-5
Formula : C2H5ClO2S
M.W : 128.58
SMILES Code : CCS(=O)(Cl)=O
MDL No. :MFCD00007460
InChI Key :FRYHCSODNHYDPU-UHFFFAOYSA-N
Pubchem ID :11667

Safety of [ 594-44-5 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H310-H314-H330
Precautionary Statements:P260-P280-P284-P302+P350-P305+P351+P338-P310
Class:6.1(8)
UN#:2927
Packing Group:

Computational Chemistry of [ 594-44-5 ] Show Less

Physicochemical Properties

Num. heavy atoms 6
Num. arom. heavy atoms 0
Fraction Csp3 1.0
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 25.49
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

42.52 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.02
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.75
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.66
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.08
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.5
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.77

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.04
Solubility 11.6 mg/ml ; 0.0904 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.22
Solubility 7.7 mg/ml ; 0.0599 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.17
Solubility 8.61 mg/ml ; 0.067 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.55 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.17

Application In Synthesis of [ 594-44-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 594-44-5 ]

[ 594-44-5 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 594-44-5 ]
  • [ 1520-70-3 ]
YieldReaction ConditionsOperation in experiment
73% Step 1: Ethylsulphonamide : The title compound was prepared using the same procedure as described in Example 12, Step 1, replacing isopropylsulphonyl chloride with ethylsulphonyl chloride. The compound was purified by trituration with hexane to give the product (6.17g, 73%) as a colourless solid. mp 53-56C. 1H NMR (360MHz, D6-DMSO) delta 1.22 (3H, t, J = 7.4Hz), 2.95 (2H, q, J = 7.4Hz), 6.69 (2H, brs).
  • 2
  • [ 7664-41-7 ]
  • [ 594-44-5 ]
  • [ 1520-70-3 ]
  • 3
  • [ 38675-10-4 ]
  • [ 594-44-5 ]
  • [ 172348-40-2 ]
  • 4
  • [ 851789-43-0 ]
  • [ 594-44-5 ]
  • [ 894773-88-7 ]
YieldReaction ConditionsOperation in experiment
100% With triethylamine; at 0℃; for 0.25h; 3-(2-Hydroxy-5-methylphenyl)-3-phenylpropanol (4.84 g, 20 mmol) is suspended in 20 ml of dichloromethane. Triethylamine (7.0 ml, 50 mmol) is added and the resulting clear solution is cooled to 0 0C. After the slow addition of ethanesulfonyl chloride (4.2 ml, 44 mmol) the mixture is stirred for 15 minutes at 0 0C. tert-Butyl methyl ether (MTBE, 100 ml) is added. The mixture is washed with 1 mol/l solution of hydrochloric acid (2 x 50 ml), 5 percent solution of sodium hydrogen carbonate (50 EPO <DP n="21"/>ml) and brine (50 ml). The organic phase is dried over anhydrous magnesium sulfate, filtrated and evaporated in vacuo to give the product as a brown oil in quantitative yield (8.5 g).1H NMR (300 MHz, CDCI3): delta [ppm] = 1.37 (3H, t, J = 7.5 Hz, CH2CH3), 1.53 (3H, t, J = 7.5 Hz, CH2CH3), 2.32 (3H1 s, CH3), 2.43 - 2.53 (2H, m, CH2), 3.07 (2H, q, J = 7.5 Hz, CH2CH3), 3.28 (2H, dq, J = 7.5, 1.4 Hz, CH2CH3), 4.22 - 4.37 (2H, m, CH2), 4.60 (1 H, t, J = 7.9 Hz1 CH), 7.02 - 7.07 (1 H, m, 1 H-Ar), 7.09 - 7.13 (1 H, m, 1 H-Ar), 7.19 - 7.35 (6H, m, 1 H-Ar, Ph).
  • 5
  • [ 120-35-4 ]
  • [ 594-44-5 ]
  • 3-Ethanesulfonylamino-4-methoxy-N-phenyl-benzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With pyridine; Example 134 3-Ethanesulfonylamino-4-methoxy-N-phenyl-benzamide Prepared according to the procedure described for Example 121 using ethanesulfonyl chloride (1.5 mL, 15.8 mmol), 3-amino-4-methoxy-N-phenyl-benzamide (2.43 g. 10 mmol) and pyridine (25 mL) to afford the product (3.023 g); m.p. 175-177 C. after trituration in hexanes/ethyl acetate (1:1).
  • 6
  • [ 240401-22-3 ]
  • [ 594-44-5 ]
  • [ 936482-02-9 ]
YieldReaction ConditionsOperation in experiment
In a dry round bottom flask was placed <strong>[240401-22-3]4-cyanopiperidinium chloride</strong> (13, 5g, 45.4 mmol) dichloromethane (150ml) and triethylamine (18.98ml, 136 mmol). To the reaction was added dropwise ethanesulfonyl chloride (4.56 ml, 45.4 mmol) and the solution stirred 1 hour and quenched with water (100 ml). The mixture was extracted with dichloromethane (3x 50 ml) and the combined organic <n="55"/>fractions dried (MgSO4), filtered, and the solvent evaporated under reduced pressure. The residue was purified by column chromatography on silica gel, eluting with EtOAc/Hexanes to give 1- (ethylsulfonyl)pirhoeridine-4-carbonitrile (14) as a white solid. MS 203 (M+l)
  • 7
  • [ 112734-22-2 ]
  • [ 594-44-5 ]
  • [ 1402586-01-9 ]
YieldReaction ConditionsOperation in experiment
79% With pyridine; at 0℃; for 1h; Step 1: (4-Bromo-2-fluorophenyl)methanamine (924 mg, 4.53 mmol) was dissolved in No.64   pyridine and No.266   ethane sulfonyl chloride (0.82 mL, 8.60 mmol) was added to the solution at 0° C. The mixture was stirred for 1 h at 0° C. Then, the mixture was quenched with 1N No.85   HCl and extracted with ethyl acetate. Drying over magnesium sulfate and evaporation of the ethyl acetate and purified by column chromatography gave No.276   N-(4-bromo-2-fluorobenzyl)-ethanesulfonamide in pure form (1.06 g, 79percent).[0518]Step 2: To a solution of No.276   N-(4-bromo-2-fluorobenzyl)ethanesulfonamide (305 mg, 1.03 mmol) in No.56   dimethylformamide, No.82   Manganese (113 mg, 2.06 mmol), No.83   (2,2?-Bipyridine)nickel(II)-dibromide (27 mg, 0.07 mmol), No.81   ethyl 2-chloropropanoate (0.17 mL, 1.34 mmol) was added. It was followed by addition of No.84   trifluoroacetic acid (0.002 mL, 0.028 mmol). The mixture was stirred for 24 h at 65° C. The reaction mixture was quenched by concentrated HCl (7 drops). Then it was extracted with diethyl ether, dried over magnesium sulfate, the solvent was evaporated in vacuo. It was purified by column chromatography to obtain No.278   ethyl 2-(4-(ethylsulfonamidomethyl)-3-fluorophenyl)propanoate in pure form (65 mg, 20percent).[0519]Step 3: To a solution of No.278   ethyl 2-(4-(ethylsulfonamidomethyl)-3-fluorophenyl)propanoate (60 mg, 0.189 mmol) in No.27   tetrahydrofuran and water co-solvent, No.88   sodium hydroxide (19 mg) was added at room temperature. The mixture was stirred for overnight and extracted with ethyl acetate, dried over magnesium sulfate, the solvent was evaporated in vacuo. It was purified by column chromatography to give No.280   2-(4-(ethylsulfonamidomethyl)-3-fluorophenyl)propanoic acid (55 mg).[0520]Step 4: No.280   2-(4-(Ethylsulfonamidomethyl)-3-fluorophenyl)propanoic acid (60 mg, 0.207 mmol) and No.36   (2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methanamine (61 mg, 0.228 mmol) was dissolved and mixed in No.32   1,4-dioxane, followed by addition of No.34   N-hydroxybenzotriazole (42 mg, 0.311 mmol) and No.33   N-(3-dimethylaminopropyl)-N?-ethylcarbodiimide (60 mg, 0.311 mmol) and No.35   triethylamine (0.07 mL, 0.518 mmol). The reaction mixture was stirred for overnight and then quenched by water and extracted with ethyl acetate. Drying over magnesium sulfate, evaporation of the ethyl acetate and purification by column chromatography gave No.282   2-(4-(ethylsulfonamidomethyl)-3-fluorophenyl)-N-((2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methyl)propanamide (example 83) in pure form (52 mg, 47percent).[0521]1H-NMR (400 MHz, CDCl3) delta 7.75 (d, 1H, J=6.40 Hz, Ar?H), 7.57 (d, 1H, J=6.36 Hz, Ar?H), 7.31 (m, 2H, Ar?H), 7.21 (m, 2H, Ar?H), 7.15 (d, 1H, J=5.92 Hz, Ar?H), 6.95 (m, 2H, Ar?H), 5.50 (m, 1H, amide-NH), 4.46 (m, 3H, amide-NH, Ar?CH2), 4.30 (d, 2H, J=5.04 Hz, Ar?CH2), 3.45 (q, 1H, J=5.68 Hz, amide-alpha-H), 2.97 (q, 2H, J=5.92 Hz, ethanesulfonly-2H), 2.37 (s, 1H, Ar?CH3), 1.43 (d, 3H, J=5.68 Hz, amide-3H), 1.30 (t, 3H, J=5.88 Hz ethanesulfonly-3H)
79% With pyridine; at 0℃; for 1h; Step 1: No.72   (4-Bromo-2-fluorophenyl)methanamine (924 mg, 4.53 mmol) was dissolved in No.73   pyridine and No.171   ethane sulfonyl chloride (0.82 mL, 8.60 mmol) was added to the solution at 0° C. The mixture was stirred for 1 h at 0° C. Then, the mixture was quenched with 1N No.56   HCl and extracted with ethyl acetate. Drying over magnesium sulfate and evaporation of the ethyl acetate and purified by column chromatography gave No.172   N-(4-bromo-2-fluorobenzyl)ethane-sulfonamide in pure form (1.06 g, 79percent).
79% With pyridine; at 0℃; for 1h; Step 1 : (4-Bromo-2-fluorophenyl)methanamine (924 mg, 4.53 mmol) was dissolved in pyridine and ethane sulfonyl chloride (0.82 mL, 8.60 mmol) was added to the solution at 0 °C. The mixture was stirred for 1 h at 0 °C. Then, the mixture was quenched with 1 N HCI and extracted with ethyl acetate. Drying over magnesium sulfate and evaporation of the ethyl acetate and purified by column chromatography gave N-(4-bromo-2-fluorobenzyl)- ethanesulfonamide in pure form (1 .06 g, 79 percent).
79% In pyridine; at 0℃; for 1h; Step 1 : (4-Bromo-2-fluorophenyl)methanamine (924 mg, 4.53 mmol) was dissolved in pyridine and ethane sulfonyl chloride (0.82 mL, 8.60 mmol) was added to the solution at 0 °C. The mixture was stirred for 1 h at 0 °C. Then, the mixture was quenched with 1 N HCI and extracted with ethyl acetate. Drying over magnesium sulfate and evaporation of the ethyl acetate and purified by column chromatography gave N-(4-bromo-2-fluorobenzyl)ethane- sulfonamide in pure form (1 .06 g, 79 percent).
79% With pyridine; at 0℃; for 1h; Step 1: (4-Bromo-2-fluorophenyl)methanamine (924 mg, 4.53 mmol) was dissolved in pyridine and ethane sulfonyl chloride (0.82 mL, 8.60 mmol) was added to the solution at 0° C. The mixture was stirred for 1 h at 0° C. Then, the mixture was quenched with 1N HCl and extracted with ethyl acetate. Drying over magnesium sulfate and evaporation of the ethyl acetate and purified by column chromatography gave N-(4-bromo-2-fluorobenzyl)-ethanesulfonamide in pure form (1.06 g, 79percent).
79% With pyridine; at 0℃; for 1h; Step 1 : (4-Bromo-2-fluorophenyl)methanamine (924 mg, 4.53 mmol) was dissolved in pyridine and ethane sulfonyl chloride (0.82 mL, 8.60 mmol) was added to the solution at 0 °C. The mixture was stirred for 1 h at 0 °C. Then, the mixture was quenched with 1 N HCI and extracted with ethyl acetate. Drying over magnesium sulfate and evaporation of the ethyl acetate and purified by column chromatography gave N-(4-bromo-2-fluorobenzyl)- ethanesulfonamide in pure form (1 .06 g, 79 percent).
79% With pyridine; at 0℃; for 1h; Step 1 : 4-Bromo-2-fluorobenzylamine (924 mg, 4.53 mmol) was dissolved in pyridine and ethane sulfonyl chloride (0.82 mL, 8.60 mmol) was added to the solution at O °C. The mixture was stirred for 1 h at O °C. Then, the mixture was quenched with 1 N HCl and extracted with ethyl acetate (EtOAc). Drying (MgSO4) and evaporation of the ethyl acetate followed and the residue was purified by CC (eluent EtOAc/n-hexane) to yield N-(4-bromo-2- fluorobenzyl)ethanesulfonamide in pure form (1 .06 g, 79 percent).

  • 8
  • [ 20876-36-2 ]
  • [ 594-44-5 ]
  • [ 921538-76-3 ]
  • 9
  • [ 6174-86-3 ]
  • [ 594-44-5 ]
  • 3-chloro-4-methyl-2-oxo-2H-chromen-7-yl ethanesulfonate [ No CAS ]
YieldReaction ConditionsOperation in experiment
81% With triethylamine; In tetrahydrofuran; at 20℃; for 4h; General procedure: Coumarin sulfonates 1-38 were synthesized by reactingdifferent hydroxylated coumarin derivatives (1 mmol) withcommercially available sulfonyl chlorides derivatives (1.2 mmol) inTHF (15 mL) and triethyl amine (1 mmol) was used as base. Reactionmixture was stirred for 4 h at room temperature to afford avariety of coumarin sulfonate esters 1e38. TLC monitoring wasused to determine the progress of the reaction. After the completionof reaction, THF was evaporated under reduced pressure andthe solid product obtained was washed with distilled water anddried under vacuum. The products were recrystallized in methanoland gave good yields. All the synthetic compounds 1-38 werecharacterized by different spectroscopic techniques such as EI-MS,HREI-MS, 1H-NMR, and 13C-NMR.
  • 10
  • [ 361345-40-6 ]
  • [ 594-44-5 ]
  • tert-butyl 4-(3-(ethylsulfonamido)benzyl)piperazine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
87.3% With pyridine; In dichloromethane; at 20℃; for 12h; A solution of <strong>[361345-40-6]tert-butyl 4-(3-aminobenzyl)piperazine-1-carboxylate</strong> (0.940 g, 3.226 mmol), pyridine (0.3 12 mL, 3.87 1 mmol) and ethanesulfonyl chloride (0.456 g, 3.548 mmol) in dichloromethane (30 mL) was stirred at the room temperature for 12 hr, Then, water was added to the reaction mixture, followed by extraction with dichloromethane. The organic layer was washed with aqueous saturated ammonium chloride solution, separated, dried with anhydrous MgSO4, filtered, and concentrated in vacuo. The residue was chromatographed (Si02, 12 g cartridge; ethyl acetate / hexane = 0 % to 40 %) to give tert-butyl 4-(3-(ethylsulfonamido)benzyl)piperazine- 1 -carboxylate as yellow solid (1.080 g, 87.3%).
  • 11
  • [ 7149-75-9 ]
  • [ 594-44-5 ]
  • N-(4-chloro-3-methylphenyl)ethanesulfonamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
53.3% With pyridine; In dichloromethane; at 20℃; for 12h; A solution of <strong>[7149-75-9]4-chloro-3-methylaniline</strong> (0.500 g, 3.53 1 mmol) and pyridine (0.427 mL, 5.297 mmol) in dichloromethane (20 mL) was mixed at the room temperature with ethanesulfonyl chloride (0.400 mL, 4.237 mmol) and stuffed at the same temperature for 12 hr. Then, aqueous 1M-hydrochloric acid solution was added to the reaction mixture, followed by extraction with dichloromethane. The bi-phasic mixture was passed through a plastic frit to remove the solid residues and aqueous layer, and the organic layer collected was concentrated in vacuo. The residue was chromatographed (Si02, 12 g cartridge; ethyl acetate / hexane = 5 percent to 50 percent) to give N(4-chloro-3-methylphenyl)ethanesulfonamide as beige solid (0.440 g, 53.3 percent).
  • 12
  • [ 62037-46-1 ]
  • [ 594-44-5 ]
  • N-(3-chloro-2-hydroxypropyl)ethane sulfonamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With dipotassium hydrogenphosphate; In tetrahydrofuran; water; at 0 - 20℃; A three-necked flask was charged with <strong>[62037-46-1]1-amino-3-chloropropyl-2-ol hydrochloride</strong> (14.60 g, 100 mmol) and tetrahydrofuran(73 mL), water (73 mL), stirred and cooled to 0 to 5 C, added with dipotassium hydrogen phosphate (34.84 g, 200 mmol), stirred for 5 minAfter the clockwise drop of ethyl sulfonyl chloride (13.50g, 105mm0l), plus the temperature after warming to room temperature for 3-4 hours, the end of the reaction0.5mol / L dilute hydrochloric acid 73mL quenching reaction, stirring and dispensing, water and then extracted with ethyl acetate 35mL 2 times, combined organic saturatedAnd washed with salt (73 mL), dried over anhydrous sodium sulfate and concentrated to give N-(3-chloro-2-hydroxypropyl) ethane sulfonamide Followed by the next step (GC purity of about 92%).
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 594-44-5 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 10147-36-1

A261628 [10147-36-1]

Propane-1-sulfonyl chloride

Similarity: 0.84

Chemical Structure| 10147-37-2

A385458 [10147-37-2]

2-Propanesulfonyl chloride

Similarity: 0.84

Chemical Structure| 35432-36-1

A433732 [35432-36-1]

2-Methylpropane-1-sulfonyl chloride

Similarity: 0.78

Chemical Structure| 1633-84-7

A529603 [1633-84-7]

4-Chloro-1-butylsulfonyl Chloride

Similarity: 0.68

Chemical Structure| 6608-47-5

A652973 [6608-47-5]

Ethenesulfonyl chloride

Similarity: 0.58

Sulfonyl Chlorides

Chemical Structure| 10147-36-1

A261628 [10147-36-1]

Propane-1-sulfonyl chloride

Similarity: 0.84

Chemical Structure| 10147-37-2

A385458 [10147-37-2]

2-Propanesulfonyl chloride

Similarity: 0.84

Chemical Structure| 35432-36-1

A433732 [35432-36-1]

2-Methylpropane-1-sulfonyl chloride

Similarity: 0.78

Chemical Structure| 139631-62-2

A742149 [139631-62-2]

Cyclopropanesulfonylchloride

Similarity: 0.72

Chemical Structure| 1220695-06-6

A513025 [1220695-06-6]

Cyclobutylmethanesulfonyl chloride

Similarity: 0.68

Chlorides

Chemical Structure| 10147-36-1

A261628 [10147-36-1]

Propane-1-sulfonyl chloride

Similarity: 0.84

Chemical Structure| 10147-37-2

A385458 [10147-37-2]

2-Propanesulfonyl chloride

Similarity: 0.84

Chemical Structure| 35432-36-1

A433732 [35432-36-1]

2-Methylpropane-1-sulfonyl chloride

Similarity: 0.78

Chemical Structure| 139631-62-2

A742149 [139631-62-2]

Cyclopropanesulfonylchloride

Similarity: 0.72

Chemical Structure| 1220695-06-6

A513025 [1220695-06-6]

Cyclobutylmethanesulfonyl chloride

Similarity: 0.68